Return to Home

Helios Technologies, Inc.

HLIO

Find Out if You Qualify for a Financial Reward by filling out the form below.

Helios Technologies, Inc. Form












Securities Fraud News does not share your information with others. There is no cost or obligation for you to submit.

Investigation Details

Helios formally announced on July 9, 2024, that Josef Matosevic, who serves as the Company’s President, Chief Executive Officer, and Director, was placed on an immediate paid leave, effective retroactively from July 1, 2024. This administrative action arose in response to allegations suggesting a potential violation of the Company’s Code of Business Conduct and Ethics. The Company has initiated an internal investigation to thoroughly examine the circumstances surrounding these allegations.

Find More Cases

Ticker Symbol Company Name Join Deadline
IOVA Iovance Biotherapeutics, Inc. July 14, 2025 Join
OGN Organon & Co. July 22, 2025 Join
VSTS Vestis Corporation August 08, 2025 Join
RCKT Rocket Pharmaceuticals, Inc. August 11, 2025 Join
CNC Centene Corporation September 08, 2025 Join